Literature DB >> 7905861

Serum measurements of soluble CD23 in HIV infection.

A S Bansal1, R S Pumphrey, B K Mandal, S H Khoo, P B Wilson.   

Abstract

A gradual reduction in cell-mediated immunity is thought to occur with the progression of human immunodeficiency virus (HIV) infection. This suggests a selective attrition of the Th1 subset. The regulation of the soluble form of the low-affinity receptor for IgE (sCD23) by the opposing actions of interleukin-4 (IL-4) and interferon-gamma (IFN-gamma) allows the assessment of the overall balance of Th1 to Th2 activity in a given disease. In order to investigate this further we employed an enhanced chemiluminescent ELISA to analyse serum levels of sCD23 in male subjects with and without HIV infection. Serum levels of sCD23 were similar in 34 HIV seronegative homosexuals, 39 homosexuals with asymptomatic HIV infection, 27 homosexuals with acquired immune deficiency syndrome (AIDS) and 20 healthy controls. This suggests that HIV has no predilection for either the Th1 or Th2 subsets of CD4 T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7905861      PMCID: PMC1422255     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  8 in total

Review 1.  CD23 and B cell activation.

Authors:  J Gordon
Journal:  Clin Exp Allergy       Date:  1992-02       Impact factor: 5.018

Review 2.  A TH1-->TH2 switch is a critical step in the etiology of HIV infection.

Authors:  M Clerici; G M Shearer
Journal:  Immunol Today       Date:  1993-03

3.  Soluble CD23 levels are elevated in the serum of patients with primary Sjögren's syndrome and systemic lupus erythematosus.

Authors:  A Bansal; T Roberts; E M Hay; R Kay; R S Pumphrey; P B Wilson
Journal:  Clin Exp Immunol       Date:  1992-09       Impact factor: 4.330

4.  Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS.

Authors:  J Embretson; M Zupancic; J L Ribas; A Burke; P Racz; K Tenner-Racz; A T Haase
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

5.  Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones.

Authors:  E Maggi; P Parronchi; R Manetti; C Simonelli; M P Piccinni; F S Rugiu; M De Carli; M Ricci; S Romagnani
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

6.  HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease.

Authors:  G Pantaleo; C Graziosi; J F Demarest; L Butini; M Montroni; C H Fox; J M Orenstein; D P Kotler; A S Fauci
Journal:  Nature       Date:  1993-03-25       Impact factor: 49.962

7.  Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity.

Authors:  A S Bansal; W Ollier; M N Marsh; R S Pumphrey; P B Wilson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

Review 8.  Defective signal transduction--a common pathway for cellular dysfunction in HIV infection?

Authors:  A J Pinching; K E Nye
Journal:  Immunol Today       Date:  1990-07
  8 in total
  2 in total

1.  The Dominant T-Helper Lymphocyte Function of HIV Infected Patients.

Authors:  András Falus; Károly Nagy; Erzsébet Temesvári; Attila Horváth
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

2.  Soluble CD23 antigen in Kawasaki disease and other acute febrile illnesses.

Authors:  T Matsubara; S Furukawa; T Motohashi; K Okumura; K Yabuta
Journal:  Eur J Pediatr       Date:  1995-10       Impact factor: 3.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.